Sd Biomed India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.19 M
as on 19-12-2024
- Revenue 118.60%
(FY 2019)
- Profit -36.74%
(FY 2019)
- Ebitda 59.18%
(FY 2019)
- Net Worth -157.03%
(FY 2019)
- Total Assets -44.40%
(FY 2019)
About Sd Biomed India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.19 M.
Gulshan Yadav and Sudarshan Yadav serve as directors at the Company.
- CIN/LLPIN
U24230MP2016PTC035484
- Company No.
035484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sd Biomed India Private Limited offer?
Sd Biomed India Private Limited offers a wide range of products and services, including Hospital and Medical Furniture, Hospital Equipment, Surgical & ICU Equipments, Oxygen Flow Meter, Oxygen & Nitrogen Gas Plants, Oxygen & Nitrogen Gas Plant, Industrial Valves & Valve Fittings, Valve Accessories, Adaptors, Plugs & Sockets, Wall Outlet.
Who are the key members and board of directors at Sd Biomed India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulshan Yadav  | Director | 03-Mar-2016 | Current |
| Sudarshan Yadav | Director | 03-Mar-2016 | Current |
Financial Performance of Sd Biomed India.
Sd Biomed India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 118.6% increase. The company also saw a substantial fall in profitability, with a 36.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 157.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sd Biomed India?
In 2018, Sd Biomed India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Dec 2023 | ₹1.19 M | Open |
How Many Employees Work at Sd Biomed India?
Sd Biomed India has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sd Biomed India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sd Biomed India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
